CMHC Spring 2021

The Cardiometabolic Challenge: Navigating a Syndemic - On Demand

Earn 14.75 Credit Hours - Free Access

Advancing the Frontiers of Cardiometabolic Care

World-renowned experts in the prevention and treatment of cardiometabolic disease present on the latest advances in obesity, hypertension, lipids, type 2 diabetes, cardiovascular disease and more. This evidence will be followed by expert panel discussions and case presentations, which will put the data into perspective and help clinicians walk away with practical clinical pearls to apply directly to patient care. Topics will include:

  • Cardio-renal risk reduction and T2DM: where do we stand in 2021
  • Advances in lipid therapy: LDL-C and beyond
  • The current state of HF prevention & treatment
  • Lifestyle interventions for multi-factorial cardiometabolic risk reduction
  • The changing paradigms of T2DM care
  • The impact of COVID-19 on cardiometabolic medicine: pre-and-post-pandemic
  • Telemedicine in Cardiometabolic Health: The Good, The Bad, and the Ugly - Practical strategies for implementation and patient care

This 2021 CMHC Spring On Demand activity highlights the latest updates in hypertension, heart failure, diabetes, dyslipidemia, lifestyle management, cardiovascular health, as well as the impacts of COVID-19 on cardiometabolic health, and translate the latest cutting-edge medical research into practical, clinical strategies for preventing, delaying, and managing cardiovascular and metabolic disorders. To view recordings from PME Symposia, please visit the PME Library located here.

Access the 2021 Spring On Demand for FREE

Direct access to the program

Agenda

Session I: Kidney Disease/Heart Failure/Hypertension

  1. Special Symposium - New Frontiers in Heart Failure Management
    Alanna A. Morris MD; Stephen D. Wiviott, MD; Ileana L. Piña, MD; Clyde W. Yancy, MD; Sarah Chuzi, MD
  2. Evaluating Risk of CKD Progression
    Joseph A. Vassalotti, MD
  3. Updates in the Prevention and Treatment of CKD
    Aldo J. Peixoto, MD
  4. Primary Aldosteronism: An Underappreciated Issue in HTN
    William F. Young, Jr., MD, MSc
  5. DKD/HTN Challenging Cases & Expert Panel Discussion
    Moderator: George L. Bakris, MD
    Panelists: Aldo J. Peixoto, MD; Ileana L. Piña, MD; Joseph A. Vassalotti, MD; William F. Young, Jr., MD, MS

Session II: Diabetes Management

  1. Glycemic Management in Patients with CVD
    Vanita R. Aroda, MD
  2. Exercise as "medicine" in the Treatment of T2DM
    Jane Reusch, MD
  3. Relationship Between TIR and Diabetes Complications
    Nicholas B. Argento, MD, FACE
  4. What is the Role of CGM in Prediabetes/Type 2 Diabetes?
    Viral Shah, MD
  5. Inpatient Use of CGM
    Joseph A. Aloi, MD
  6. Challenging Cases & Expert Panel Discussion
    Moderator: Anne L. Peters, MD
    Panelists: Grazia Aleppo, MD, FACE, FACP; Joseph A. Aloi, MD; Vanita Aroda, MD; Nicholas B. Argento, MD, FAC; Jane Reusch, MD; Viral Shah, MD

Session III: Obesity and Lifestyle Medicine

  1. The Evolving Landscape of Obesity Management - A 2021 Update
    Louis J. Aronne, MD
  2. Practical Tips to Help Your Patients Succeed in Their Weight Loss Journey
    Donna H. Ryan, MD
  3. Challenging Cases & Panel Discussion - Practical Approaches to Weight Reduction
    Moderator: Robert H. Eckel, MD
    Panelists: Louis J. Aronne, MD; Donna H. Ryan, MD
  4. Expert Perspectives - Best Approaches to Diets for Cardiometabolic Health
    Kim A. Williams, Sr., MD; Penny M. Kris-Etherton, PhD; Sarah Hallberg, DO
  5. Challenging Cases & Expert Panel Discussion
    Moderator: Robert H. Eckel, MD
    Panelists: Penny M. Kris-Etherton, PhD; Sarah Hallberg, DO; Kim A. Williams, Sr., MD

Session IV: Dyslipidemia, Atherosclerosis, & Thrombosis

  1. Risk Prediction: Role of Imaging, Biomarkers, and Genetics
    Matthew J. Budoff, MD
  2. Update on Inflammation and CVD
    Brendan M. Everett, MD
  3. Post-MI: When to Start Lipid-lowering Therapy and How Low to Go
    Pamela B. Morris, MD
  4. Stroke Prevention in the Cardiometabolic Patient With Atrial Fibrillation
    Elaine M. Hylek, MD
  5. Challenging Cases & Expert Panel Discussion
    Moderator: Christie M. Ballantyne, MD Panelists: Deepak L. Bhatt, MD; Matthew J. Budoff, MD; Robert H. Eckel, MD; Brendan M. Everett, MD; Elaine M. Hylek, MD; Margo B. Minissian, PhD, ACNP, NEA-BC, FNLA, FAHA; Pamela B. Morris, MD

Session V: Cardiometabolic Risk and COVID-19

  1. Impacts of COVID-19 on Cardiometabolic Risk
    • COVID-19 & Obesity Chip Lavie, MD
    • COVID-19 & Cardiovascular Disease Clyde W. Yancy, MD
    • Diabetes and COVID: A bidirectional relationship Jay H. Shubrook DO FACOFP, FAAFP
  2. Challenging Cases & Expert Panel Discussion: COVID-19 and Cardiometabolic Diseases
    Moderator: Robert H. Eckel, MD Panelists: Ileana L. Piña, MD; Chip Lavie, MD; Margo B. Minissian, PhD, ACNP, NEA-BC, FNLA, FAHA; Jay H. Shubrook DO FACOFP, FAAFP; Clyde W. Yancy, MD
  3. Telemedicine in Cardiometabolic Health: The Good, The Bad, and The Ugly
    • Improving the Management of Obesity with Telemedicine Bartolome Burguera, MD, PhD
    • Telemedicine and Hypertension Assessment and Management
    • Daichi Shimbo, MD
    • Telemedicine and Glucose Monitoring Anne L. Peters, MD
    • Optimizing reimbursement in telemedicine Ahmed M. Soliman, MD
  4. Challenging Cases & Expert Panel Discussion
    Moderator: Robert H. Eckel, MD Panelists: Bartolome Burguera, MD, PhD; Anne L. Peters, MD; Daichi Shimbo, MD; Ahmed M. Soliman, MD